SCIENTIFIC BACKGROUND

MVK

Mevalonate aciduria (MA) and hyper-IgD-and-periodic fever syndrome (HIDS) represent the two ends of the spectrum of clinical symptoms of mevalonate kinase deficiency (MKD). The severity of symptoms here depends on the remaining enzyme activity of mevalonate kinase; in HIDS it is approximately 10%, in MA <0.5%.

 

HIDS is one of the rare congenital periodic fever syndromes; a few hundred cases of HIDS are thought to occur worldwide. The disease is inherited in an autosomal recessive manner and almost invariably manifests in early childhood, usually in the first year of life. Febrile episodes usually occur every 4-8 weeks and last approximately 3-7 days. In up to 50% of cases, they are triggered by certain triggers, usually vaccinations, stress, and infections. The relapses are typically accompanied by cervical lymphadenopathy, arthritis/arthralgias, measles-like exanthema, and abdominal pain with diarrhea and vomiting. Usually, the specific symptoms are preceded by marked headache and chills. The development of amyloidosis is very rare. There is usually a continuous elevation of IgD (and IgA) serum concentrations above 100 IU/ml, but in about 20% of cases, especially in young children, IgD levels may be within normal limits. There are currently no accepted guidelines for the treatment of HIDS. In addition to non-steroidal anti-inflammatory drugs, corticosteroids are initially used during febrile episodes. In severe courses of the disease, treatment with IL1 blockers seems to be most promising.

 

Symptoms of MA include psychomotor retardation, failure to thrive, progressive cerebellar ataxia, dysmorphia, progressive loss of vision, and recurrent fevers. Life expectancy is often limited.

 

Both diseases are caused by mutations in the MVK gene, which encodes mevalonate kinase, a key enzyme in cholesterol biosynthesis. The relationship between defect in cholesterol biosynthesis and autoinflammatory disease pattern is still unclear. In about 80% of HIDS patients, the mutation V377I in exon 11 is present in homozygous form or in combination with a second mutation.

 

References
Gattorno et al. 2019, Ann Rheum Dis 78:1025 / Martorana et al. 2017, Front Immunol 8:344 / van der Burgh et al. 2013, Clin Immunol 147:197 / Mandey et al. 2006, Hum Mut 27:796

GENES

MVK

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Exciting news in genetic research! The Human Pangenome Reference Consortium has unveiled an improved version of the human pangenome reference. This c...

Read more

Duchenne muscular dystrophy, a rare inherited muscle disorder characterized by progressive muscle weakness and degeneration that leads to difficultie...

Read more

May 12 is International Nurses Day. It is celebrated on Florence Nightingale’s birthday. She pioneered the field of modern nursing through her dedi...

Read more

Hair loss is a common problem that affects millions of men and women around the world. While genetics is believed to be the most significant factor c...

Read more

Depression is a serious mental health issue affecting over 280 million people worldwide. Recent research has revealed a potential link between gut he...

Read more

If you are unlucky enough to suffer from migraines, you will know that a migraine is not just a bad headache. The headache and accompanying symptoms ...

Read more

Autism spectrum disorder (ASD) is a neurological developmental disorder that affects brain development and function. This affects how people learn, b...

Read more

Researchers have developed a method called "Mendelian Phenotype Search Engine" (MPSE) to identify which sick infants in the neonatal intensive care u...

Read more

Did you know that wisdom teeth are actually an evolutionary leftover from our ancient ancestors that no longer serve their original purpose? These mo...

Read more

Azoospermia is a medical condition characterized by the absence of sperm in the ejaculate and is a major cause of male infertility. It affects 1 in 1...

Read more